This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Drug repurposing: a systematic review on root causes, barriers and facilitators
BMC Health Services Research Open Access 29 July 2022
-
Considerations and challenges for sex-aware drug repurposing
Biology of Sex Differences Open Access 25 March 2022
-
The druggable schizophrenia genome: from repurposing opportunities to unexplored drug targets
npj Genomic Medicine Open Access 25 March 2022
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Kathiresan, S. et al. Nat. Genet. 40, 189–197 (2008).
Franke, A. et al. Nat. Genet. 42, 1118–1125 (2010).
Moschen, A.R. et al. Gut 54, 479–487 (2005).
Stefansson, H. et al. Nat. Genet. 41, 277–279 (2009).
Clark, L.N. et al. Eur. J. Hum. Genet. 18, 838–843 (2010).
Louis, E.D. Lancet Neurol. 4, 100–110 (2005).
Tobacco and Genetics Consortium. Nat. Genet. 42, 441–447 (2010).
Stuart, P.E. et al. Nat. Genet. 42, 1000–1004 (2010).
Ormerod, A.D. et al. Arch. Dermatol. Res. 290, 3–8 (1998).
Ormerod, A.D. et al. Br. J. Dermatol. 142, 985–990 (2000).
Welsh, P. et al. J. Clin. Endocrinol. Metab. 95, 93–99 (2010).
Xu, K. & Coté, T.R. Brief. Bioinform. 12, 341–345 (2011).
Nair, R.P. et al. Nat. Genet. 41, 199–204 (2009).
Styrkarsdottir, U. et al. Nat. Genet. 41, 15–17 (2009).
Zeggini, E. et al. Science 316, 1336–1341 (2007).
Imielinski, M. et al. Nat. Genet. 41, 1335–1340 (2009).
Barrett, J.C. et al. Nat. Genet. 40, 955–962 (2008).
Anderson, C.A. et al. Nat. Genet. 43, 246–252 (2011).
Dubois, P.C. et al. Nat. Genet. 42, 295–302 (2010).
Baratz, K.H. et al. N. Engl. J. Med. 363, 1016–1024 (2010).
Acknowledgements
The authors thank K. Peters for helpful comments on this manuscript. T.P. holds a Canada Research Chair and is supported by the Canadian Institutes of Health Research (CIHR). J.B.R. is supported by the CIHR, Ministere Développement Economique, Innovation et Exportation du Québec, Fonds de la Recherche en Santé du Québec, Lady Davis Institute of Medical Research.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
P.X.S. is a full-time employee of GlaxoSmithKline, a pharmaceutical company.
Supplementary information
Rights and permissions
About this article
Cite this article
Sanseau, P., Agarwal, P., Barnes, M. et al. Use of genome-wide association studies for drug repositioning. Nat Biotechnol 30, 317–320 (2012). https://doi.org/10.1038/nbt.2151
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.2151
This article is cited by
-
Genetic and Gene Expression Resources for Osteoporosis and Bone Biology Research
Current Osteoporosis Reports (2023)
-
Drug repurposing: a systematic review on root causes, barriers and facilitators
BMC Health Services Research (2022)
-
Considerations and challenges for sex-aware drug repurposing
Biology of Sex Differences (2022)
-
The druggable schizophrenia genome: from repurposing opportunities to unexplored drug targets
npj Genomic Medicine (2022)
-
Twelve years of GWAS discoveries for osteoporosis and related traits: advances, challenges and applications
Bone Research (2021)